Ageing Europe - statistics on population developments [cited 2023 Oct 31]. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Ageing_Europe_-_statistics_on_population_developments#Older_people_.E2.80.94_population_overview.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-156. https://doi.org/10.1093/gerona/56.3.M146.

Article  CAS  Google Scholar 

Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hébert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353:205–6. https://doi.org/10.1016/S0140-6736(98)04402-X.

Article  CAS  Google Scholar 

Eckerblad J, Theander K, Ekdahl A, Unosson M, Wirehn A-B, Milberg A, et al. Symptom burden in community-dwelling older people with multimorbidity: a cross-sectional study. BMC Geriatr. 2015;15:1. https://doi.org/10.1186/1471-2318-15-1.

Article  Google Scholar 

Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63:187–95. https://doi.org/10.1111/j.1365-2125.2006.02744.x.

Article  Google Scholar 

Lövheim H, Sandman P-O, Kallin K, Karlsson S, Gustafson Y. Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. Int Psychogeriatr. 2006;18:713–26. https://doi.org/10.1017/S1041610206003930.

Article  Google Scholar 

Weich S, Pearce HL, Croft P, Singh S, Crome I, Bashford J, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ. 2014;348: g1996. https://doi.org/10.1136/bmj.g1996.

Article  CAS  Google Scholar 

Dedhiya SD, Hancock E, Craig BA, Doebbeling CC, Thomas J. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother. 2010;8:562–70. https://doi.org/10.1016/S1543-5946(10)80005-4.

Article  Google Scholar 

Rogowska M, Thornton M, Creese B, Velayudhan L, Aarsland D, Ballard C, et al. Implications of adverse outcomes associated with antipsychotics in older patients with dementia: a 2011–2022 update. Drugs Aging. 2023;40:21–32. https://doi.org/10.1007/s40266-022-00992-5.

Article  Google Scholar 

Yunusa I, Alsumali A, Garba AE, Regestein QR, Eguale T. Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia. JAMA Netw Open. 2019;2: e190828. https://doi.org/10.1001/jamanetworkopen.2019.0828.

Article  Google Scholar 

Yunusa I, Rashid N, Demos GN, Mahadik BS, Abler VC, Rajagopalan K. Comparative outcomes of commonly used off-label atypical antipsychotics in the treatment of dementia-related psychosis: a network meta-analysis. Adv Ther. 2022;39:1993–2008. https://doi.org/10.1007/s12325-022-02075-8.

Article  CAS  Google Scholar 

Schmucker DL. Aging and the liver: an update. J Gerontol A Biol Sci Med Sci. 1998;53:B315-320. https://doi.org/10.1093/gerona/53A.5.B315.

Article  CAS  Google Scholar 

Drenth-van Maanen AC, van Marum RJ, Knol W, van der Linden CMJ, Jansen PAF. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging. 2009;26:687–701. https://doi.org/10.2165/11316400-000000000-00000.

Article  Google Scholar 

Hutchison LC, O’Brien CE. Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Pract. 2007;20:4–12. https://doi.org/10.1177/0897190007304657.

Article  Google Scholar 

Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13:74. https://doi.org/10.1186/s12916-015-0322-7.

Article  CAS  Google Scholar 

Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38:360–72. https://doi.org/10.1111/jcpt.12059.

Article  CAS  Google Scholar 

Curtin D, Gallagher PF, O’Mahony D. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019;10:204209861982943. https://doi.org/10.1177/2042098619829431.

Article  Google Scholar 

Pazan F, Weiss C, Wehling M, FORTA, Bauer JM, Berthold HK, et al. The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults. Drugs Aging. 2022;39:245–7. https://doi.org/10.1007/s40266-022-00922-5.

Article  Google Scholar 

ICD-9-CM: International Classification of Diseases 9th Revision Clinical Modification. 5th ed. Medicode; 1997.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Arlington; American Psychiatric Association; 1994

By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults: 2019 AGS BEERS Criteria® Update Expert Panel. J Am Geriatr Soc. 2019;67:674–94.https://doi.org/10.1111/jgs.15767

Pasina L, Astuto S, Cortesi L, Tettamanti M, Franchi C, Marengoni A, et al. Therapeutic duplicates in a cohort of hospitalized elderly patients: results from the REPOSI study. Drugs Aging. 2016;33:647–54. https://doi.org/10.1007/s40266-016-0395-9.

Article  Google Scholar 

Eggermont LHP, de Vries K, Scherder EJA. Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia. Int Psychogeriatr. 2009;21:286–94. https://doi.org/10.1017/S1041610209008552.

Article  Google Scholar 

Wetzels RB, Zuidema SU, de Jonghe JFM, Verhey FRJ, Koopmans RTCM. Prescribing pattern of psychotropic drugs in nursing home residents with dementia. Int Psychogeriatr. 2011;23:1249–59. https://doi.org/10.1017/S1041610211000755.

Article  CAS  Google Scholar 

Nijk RM, Zuidema SU, Koopmans RTCM. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. Int Psychogeriatr. 2009;21:485–93. https://doi.org/10.1002/gps.5116.

Article  Google Scholar 

Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89:845–54. https://doi.org/10.1038/clpt.2011.44.

Article  CAS  Google Scholar 

Dalleur O, Boland B, Losseau C, Henrard S, Wouters D, Speybroeck N, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31:291–8. https://doi.org/10.1007/s40266-014-0157-5.

Article  CAS  Google Scholar 

Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62:1658–65. https://doi.org/10.1111/jgs.12993.

Article  Google Scholar 

Wehling M, Burkhardt H, Kuhn-Thiel A, Pazan F, Throm C, Weiss C, et al. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. Age Ageing. 2016;45:262–7. https://doi.org/10.1093/ageing/afv200.

Article  Google Scholar 

Awad A, Hanna O. Potentially inappropriate medication use among geriatric patients in primary care setting: a cross-sectional study using the Beers, STOPP, FORTA and MAI criteria. PLoS ONE. 2019;14: e0218174. https://doi.org/10.1371/journal.pone.0218174.

Article  CAS  Google Scholar 

Pazan F, Weiss C, Wehling M, Wehling M, Burkhardt H, Schwarz S, et al. The FORTA (Fit fOR The Aged) list 2018: third version of a validated clinical tool for improved drug treatment in older people. Drugs Aging. 2019;36:481–4. https://doi.org/10.1007/s40266-019-00669-6.

Article  Google Scholar 

Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113–21. https://doi.org/10.1111/j.1365-2710.2007.00793.x.

Article  CAS  Google Scholar 

O’Connor MN, O’Sullivan D, Gallagher PF, Eustace J, Byrne S, O’Mahony D. Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons’ prescriptions and screening tool to alert to right treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc. 2016;64:1558–66. https://doi.org/10.1111/jgs.14312.

Article  Google Scholar 

Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiat. 2015;72:438–45. https://doi.org/10.1001/jamapsychiatry.2014.3018.

Article  Google Scholar 

Pasina L, Novella A, Cortesi L, Nobili A, Tettamanti M, Ianes A. Drug prescriptions in nursing home residents: an Italian multicenter observational study. Eur J Clin Pharmacol. 2020;76:1011–9. https://doi.org/10.1007/s00228-020-02871-7.

Article  Google Scholar 

O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8. https://doi.org/10.1093/ageing/afu145.

Article  Google Scholar